Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001641241-21-000002
Filing Date
2021-10-06
Accepted
2021-10-05 18:31:28
Documents
1
Effectiveness Date
2021-10-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7885
  Complete submission text file 0001641241-21-000002.txt   8946
Mailing Address 1201 BOYLSTON AVE. UNIT 417 SEATTLE WA 98101
Business Address 1201 BOYLSTON AVE. UNIT 417 SEATTLE WA 98101 6178182334
Cyrus Biotechnology, Inc. (Filer) CIK: 0001641241 (see all company filings)

EIN.: 471015686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-405369 | Film No.: 211308159